Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Research Grant, 2018
    Assessing the Effects of Parkin Activation in Pre-clinical Models

    Study Rationale:
    Protein parkin is involved in several subtypes of Parkinson's disease (PD). Loss of its activity leads to early-onset Parkinson's; therefore, increasing parkin activity may improve...

  • Research Grant, 2018
    The Role of LRRK2 in Immune Response and Neurodegeneration Caused by Mitochondrial Dysfunction

    Study Rationale:
    Although mutations (changes) in the LRRK2 gene are more common than changes in other disease-linked genes in people with Parkinson's disease (PD), it remains unclear how the LRRK2 mut...

  • Alpha-Synuclein Biology and Therapies, 2018
    Studying the Function of Modified Alpha-synuclein in Health and Disease

    Study Rationale:
    The exact cause of brain cell death in people with Parkinson's disease (PD) is not fully understood. Studies have revealed clumps of protein alpha-synuclein in brain cells. Modified...

  • Research Grant, 2018
    Gait as a Measure of Parkinson's Disease

    Study Rationale:
    Gait impairment -- difficulty walking -- is arguably among the most disabling symptoms of Parkinson's disease (PD), as safe walking is critical for maintaining independence and...

  • Research Grant, 2018
    Using Deep Learning to Evaluate Changes Associated with Parkinson’s Disease

    Study Rationale:
    Recent advances in artificial intelligence and, in particular, in one of its methods called deep learning offer exciting opportunities for the diagnosis and treatment of Parkinson’s...

  • Research Grant, 2018
    Developing TLR2-Blocking Drugs to Reduce Alpha-synuclein-Induced Inflammation in Parkinson's Disease

    Promising Outcomes of Original Grant: 100 words)
    Synucleinopathies, including Parkinson's disease (PD), is a group of disorders affecting the central nervous system (CNS). These disorders share one key...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.